BEAM
Beam Therapeutics Inc
NASDAQ: BEAM · HEALTHCARE · BIOTECHNOLOGY
$29.38
-3.86% today
Updated 2026-04-29
Market cap
$3.02B
P/E ratio
—
P/S ratio
21.60x
EPS (TTM)
$-0.81
Dividend yield
—
52W range
$15 – $36
Volume
2.1M
Beam Therapeutics Inc (BEAM) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+49.8%
Last 4 quarters
Revenue YoY growth
+279.5%
Most recent quarter
EPS YoY growth
+313.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.5%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-4.9%
2025-11-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-24 | $2.33 | +330.7% | $28.33 | $29.61 | +4.5% |
| 2025-11-04 | $-1.10 | -4.8% | $24.25 | $23.07 | -4.9% |
| 2025-08-05 | $-1.00 | +9.9% | $19.12 | $18.30 | -4.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.01 | $2.33 | +330.7% | $114.11M | +279.5% |
| 2025-09-30 | $-1.05 | $-1.10 | -4.8% | $9.70M | -32.0% |
| 2025-06-30 | $-1.11 | $-1.00 | +9.9% | $8.47M | -28.1% |
| 2025-03-31 | $-1.17 | $-1.24 | -6.0% | $7.47M | +0.8% |
| 2024-12-31 | $-1.22 | $-1.09 | +10.3% | $30.07M | -90.5% |
| 2024-09-30 | $-1.16 | $-1.17 | -0.9% | $14.27M | -17.0% |
| 2024-06-30 | $-1.13 | $-1.11 | +1.8% | $11.77M | -41.5% |
| 2024-03-31 | $-1.42 | $-1.21 | +14.8% | $7.41M | — |
| 2023-12-31 | $-1.01 | $1.73 | +271.3% | $316.19M | — |
| 2023-09-30 | $-1.36 | $-1.22 | +10.3% | $17.19M | — |
| 2023-06-30 | $-1.42 | $-1.08 | +23.9% | $20.12M | — |
Frequently asked questions
Has Beam Therapeutics Inc beaten earnings estimates?
Beam Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +49.8% over the last 4 quarters.
How does BEAM stock react to earnings?
BEAM stock has moved an average of -1.5% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Beam Therapeutics Inc's revenue growth rate?
Beam Therapeutics Inc reported year-over-year revenue growth of +279.5% in its most recent quarter, with EPS growing +313.8% year-over-year.